Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes

被引:0
|
作者
Patel, Kruti [1 ]
Bora, Vivek [1 ]
Patel, Bhoomika [2 ]
机构
[1] Nirma Univ, Inst Pharm, Ahmadabad, India
[2] Natl Forens Sci Univ, Sect 9, Gandhinagar 382007, Gujarat, India
关键词
Sodium orthovanadate; Diabetes mellitus; Colon cancer; PTP1b; Apoptosis; Angiogenesis; TYROSINE-PHOSPHATASE; 1B; EMBRYO CHORIOALLANTOIC MEMBRANE; COLORECTAL-CANCER; CELLS IMPLICATIONS; OXIDATIVE STRESS; E-CADHERIN; PTP1B; RECEPTOR; INHIBITION; EXPRESSION;
D O I
10.1007/s00280-023-04596-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe presence of type 2 diabetes mellitus increases the risk of developing the colon cancer. The main objective of this study was to determine the role of sodium orthovanadate (SOV) in colon cancer associated with diabetes mellitus by targeting the competitive inhibition of PTP1B.MethodsFor in vivo study, high fat diet with low dose streptozotocin model was used for inducing the diabetes mellitus. Colon cancer was induced by injecting 1,2-dimethylhydrazine (25 mg/kg, sc) twice a week. TNM staging and immunohistochemistry (IHC) was carried out for colon cancer tissues. In vitro studies like MTT assay, clonogenic assay, rhodamine-123 dye assay and annexin V-FITC assay using flow cytometry were performed on HCT-116 cell line. CAM assay was performed to examine the anti-angiogenic effect of the drug.ResultsSodium orthovanadate reduces the blood glucose level and tumor parameters in the animals. In vitro studies revealed that SOV decreased cell proliferation dose dependently. In addition, SOV induced apoptosis as depicted from rhodamine-123 dye assay and annexin V-FITC assay using flow cytometry as well as p53 IHC staining. SOV showed reduced angiogenesis effect on eggs which was depicted from CAM assay and also from CD34 and E-cadherin IHC staining.ConclusionsOur data suggest that SOV exhibits protective role in colon cancer associated with diabetes mellitus. SOV exhibits anti-proliferative, anti-angiogenic and apoptotic inducing effects hence can be considered for therapeutic switching in diabetic colon cancer.
引用
收藏
页码:55 / 70
页数:16
相关论文
共 29 条
  • [21] THE MECHANISM OF BLOOD PRESSURE-LOWERING EFFECT OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN PATIENTS WITH OBESE TYPE 2 DIABETES MELLITUS
    Kawasoe, Mariko
    Kawasoe, Shin
    Maruguchi, Yukiko
    Uenomachi, Hitoshi
    Kajiya, Shoko
    Kubozono, Takuro
    Miyata, Masaaki
    Ohishi, Mitsuru
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1940 - 1940
  • [22] PRONOUNCED BLOOD GLUCOSE-LOWERING EFFECT OF THE ANTILIPOLYTIC DRUG ACIPIMOX IN NONINSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS DURING A 3-DAY INTENSIFIED TREATMENT PERIOD
    WORM, D
    HENRIKSEN, JE
    VAAG, A
    THYERONN, P
    MELANDER, A
    BECKNIELSEN, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (03): : 717 - 721
  • [23] Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival
    Katayama, Daisuke
    Yanagawa, Masahiro
    Matsunaga, Keiko
    Watabe, Hiroshi
    Watabe, Tadashi
    Kato, Hiroki
    Kijima, Takashi
    Takeda, Yoshito
    Kumanogoh, Atsushi
    Shimosegawa, Eku
    Hatazawa, Jun
    Tomiyama, Noriyuki
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival
    Daisuke Katayama
    Masahiro Yanagawa
    Keiko Matsunaga
    Hiroshi Watabe
    Tadashi Watabe
    Hiroki Kato
    Takashi Kijima
    Yoshito Takeda
    Atsushi Kumanogoh
    Eku Shimosegawa
    Jun Hatazawa
    Noriyuki Tomiyama
    Scientific Reports, 11
  • [25] Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension
    Amin, N. B.
    Wang, X.
    Mitchell, J. R.
    Lee, D. S.
    Nucci, G.
    Rusnak, J. M.
    DIABETES OBESITY & METABOLISM, 2015, 17 (08): : 805 - 808
  • [26] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Currie CJ [letter]
    Ranc, Kristina
    Jorgensen, Marit E.
    Friis, Soren
    Carstensen, Bendix
    DIABETOLOGIA, 2014, 57 (09) : 2003 - 2004
  • [27] Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Reply to Holden SE, Bannister CA, Currie CJ [letter]
    Kristina Ranc
    Marit E. Jørgensen
    Søren Friis
    Bendix Carstensen
    Diabetologia, 2014, 57 : 2003 - 2004
  • [28] Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study
    Kario, Kazuomi
    Okada, Kenta
    Kato, Mitsutoshi
    Nishizawa, Masafumi
    Yoshida, Tetsuro
    Asano, Tsuguyoshi
    Uchiyama, Kazuaki
    Niijima, Yawara
    Katsuya, Tomohiro
    Urata, Hidenori
    Osuga, Jun-ichi
    Fujiwara, Takeshi
    Yamazaki, Shoji
    Tomitani, Naoko
    Kanegae, Hiroshi
    CIRCULATION, 2019, 139 (18) : 2089 - 2097
  • [29] Twenty-four hour blood pressure-lowering effect of a sodium-glucose cotransporter-2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension - results from the randomized, placebo-controlled SACRA study
    Koppelstaetter, Christian
    JOURNAL FUR HYPERTONIE, 2019, 23 (02): : 57 - 58